Skip to content

Clinical trials

Phase 2 Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20061
20083
20092
20112
20123
20132
20142
20171
20232
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting2
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Abbott3
KAI Pharmaceuticals3
Shaanxi Micot Pharmaceutical Technology Co., Ltd.3
Deltanoid Pharmaceuticals2
OPKO Health, Inc.2
Shanghai Hengrui Pharmaceutical Co., Ltd.2
Astellas Pharma Inc1
Iain Bressendorff1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary27
Renal Insufficiency, Chronic6
Kidney Failure, Chronic5
Chronic Kidney Disease-Mineral and Bone Disorder3
Hyperparathyroidism1
Kidney Diseases1
Parathyroid Diseases1
Renal Insufficiency1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.